Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 58. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period725
The potential rationale of COVID‐19 vaccine‐induced myopericarditis471
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic415
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries265
248
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection218
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis210
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains207
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients194
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy184
Issue Information180
166
Issue Information157
Association of Remdesivir use with bradycardia: A systematic review and meta‐analysis157
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children138
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort130
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples126
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters123
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022114
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B114
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India112
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China111
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity109
Repurposing of the antibiotic nitroxoline for the treatment of mpox99
Prevalence of Human Herpesvirus 8 Infection in Patients With Type 2 Diabetes and Blood Donors95
Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases93
Pexophagy Triggered by Enterovirus 71 Modulates the Production of Pro‐Inflammatory Cytokines Through Cholesterol Accumulation in Lysosomes93
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters91
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting89
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity86
Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay86
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study84
Monkeypox Virus Subverts the Inflammatory Response of Macrophages at the Maternal‐Fetal Interface83
Inhibiting cardiac autophagy suppresses Zika virus replication83
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function82
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study79
Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips75
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety70
An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant69
Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study69
Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines68
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond68
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 267
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer67
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial66
No signs of “tripledemic” in Finnish children66
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor64
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic63
Corrigendum63
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV63
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico62
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults62
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma62
Molecular epidemiology of SARS‐CoV‐2 variants in circulation in the state of Maranhão, Brazil62
Issue Information62
Risks of catching COVID‐19 according to vaccination status of healthcare workers during the SARS‐CoV‐2 Delta variant dominant period and their clinical characteristics61
Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV‐1 from Guangzhou, China60
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients59
Erratum58
Correction to “Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C”58
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”58
0.20733213424683